Mitochondrial calcium uptake in Alzheimer’s disease
Mitochondrial calcium uptake in Alzheimer’s disease
批准号:
10668706
负责人:
Pooja Jadiya
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-15 至 2025-08-31
关键词:
3xTg-AD mouseAbeta clearanceAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-ProteinAmyloidosisAutophagocytosisBrainCalciumCause of DeathCell DeathCell LineCell RespirationCellular StressClinicalCoupledDataDefectDevelopmentDiseaseDisease ProgressionEconomic BurdenEventExhibitsGenerationsGenesGeneticGenetic ModelsHomeostasisImpaired cognitionImpairmentLinkMediatingMedical Care CostsMemoryMemory LossMetabolicMetabolic dysfunctionMitochondriaMitochondrial MatrixModelingMolecularMolecular WeightMusMutant Strains MiceNerve DegenerationNeurofibrillary TanglesNeuronal DysfunctionNeuronsOxidative StressPathogenesisPathogenicityPathologicPathologyPathway interactionsPhaseReactive Oxygen SpeciesReportingResearchRoleSamplingSenile PlaquesSignal PathwaySignal TransductionStructureSynapsesTestingTimeToxic effectTrainingTransgenic Miceabeta depositionage relatedcalcium uniportercareercognitive skillextracellulargain of functionhyperphosphorylated tauliver injurymisfolded proteinmitochondrial dysfunctionmutantneuron lossneuropathologynew therapeutic targetnovel therapeutic interventionoverexpressionparalogous geneprotein aggregationproteostasisscaffoldstoichiometrytau Proteinsuptake
中文摘要
摘要:
阿尔茨海默病(AD)的特征是记忆丧失并伴有神经细胞死亡和
代谢功能障碍。许多研究已经报道了神经细胞内钙离子的失调。
(1)钙信号转导是AD发病机制中的早期事件。据认为,神经元1Ca~(2+)的持续升高
促进线粒体钙的过度摄取,但到目前为止还没有研究证实这一作用
线粒体钙摄取与疾病进展的关系。由于mCa~(2+)流量是细胞呼吸的重要调节因子
细胞死亡,这两个都参与了AD的发病,我们假设mCa2+超载是一个关键
导致AD病理改变,并可能导致代谢缺陷和神经元死亡。定义…的角色
我们已经产生了3xTg-AD突变小鼠,其神经元特异性缺失了
线粒体钙统一转运体(MCU),这是线粒体钙摄取所必需的。此外,我们还生成了一个
表达最近发现的线粒体钙单转运体β亚基的功能获得突变小鼠
(MCUb)。MCUb最近被报道为mCa~(2+)摄取的负调节因子,我们观察到
它在AD中的表达发生了实质性的变化。这些模型将允许因果实验来测试mCa2+
摄取推动AD的进展。将检查小鼠的记忆变化,淀粉样变性,tau病理,
氧化应激、突触和代谢功能。初步数据表明,mCa~(2+)摄取过载会损害
清除错误折叠的蛋白质和功能失调的线粒体。因此,我们将机械地审查
钙离子交换与自噬和有丝分裂途径之间的联系。最好的情况是,拟议的研究
将发现AD和相关线粒体功能障碍的新治疗靶点,并提供培训
和研究平台,推动PIS自主研究事业。
英文摘要
Abstract:
Alzheimer's disease (AD) is characterized by the loss of memory accompanied by neuronal cell death and
metabolic dysfunction. Numerous studies have reported a dysregulation in neuronal intracellular calcium
(1Ca2+) signaling as an early event in AD pathogenesis. It is thought that a prolonged elevation in neuronal 1Ca2+
promotes excessive mitochondrial calcium (mCa2+) uptake, yet to date no study has examined the contribution
of mCa2+ uptake to disease progression. Since mCa2+ flux is an important regulator of cellular respiration and
cell death, both of which are involved in AD pathogenesis, we hypothesize that mCa2+ overload is a key
contributor to AD pathology and may contribute to metabolic deficits and neuronal demise. To define the role of
mCa2+ exchange in AD we have generated 3xTg-AD mutant mice with neuronal-specific deletion of
Mitochondrial Calcium Uniporter (MCU), which is required for mCa2+ uptake. In addition, we have generated a
gain-of-function mutant mouse expressing the recently identified mitochondrial calcium uniporter beta subunit
(MCUb). MCUb was recently reported as a negative regulator of mCa2+ uptake and we have observed
substantial changes in its expression in AD. These models will allow causative experimentation to test if mCa2+
uptake drives AD progression. Mice will be examined for alterations in memory, amyloidosis, tau-pathology,
oxidative stress, synaptic and metabolic function. Preliminary data suggest that mCa2+ uptake overload impairs
the clearance of misfolded proteins and dysfunctional mitochondria. Therefore, we will mechanistically examine
the link between mCa2+ exchange and autophagic and mitophagic pathways. Optimally, the proposed studies
will discover new therapeutic targets for AD and associated mitochondrial dysfunction and provide a training
and research platform to promote the Pis independent research career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial calcium uptake in Alzheimer’s disease
-
批准号:10689146
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer's disease
-
批准号:10239248
-
项目类别:
-
资助金额:$10.41万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer's disease. Admin Supplement
-
批准号:10782299
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer's disease
-
批准号:10055513
-
项目类别:
-
资助金额:$10.41万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
海外基金